3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Completed
4
Recruiting
2
Withdrawn
1
Unknown
1
Not yet recruiting
1
Sponsor Class
OTHER
1
NETWORK
1
Study Type
Interventional
2
Sponsor
Cancer Type
Breast
1
Conditions
Stomatitis
2
Neoplasms
2
Head and Neck Neoplasms
2
Breast Neoplasms
2
Radiation Induced Xerostomia
1
Radiation Fibrosis Syndrome
1
Mouth Neoplasms
1
Lymphedema
1
Hematologic Neoplasms
1
Hand-Foot Syndrome
1
Graft vs Host Disease
1
Cognitive Dysfunction
1
Breast Cancer Lymphedema
1
Interventions
pembrolizumab
38
Blood Specimen Collection
38
Bevacizumab
22
Surveys and Questionnaires
18
Standard of Care
18
Radiotherapy
17
Exercise
17
Carboplatin
17
Nivolumab
15
atezolizumab
14
Paclitaxel
14
Cisplatin
14
Drug Therapy
13
Fluorouracil
12
Cyclophosphamide
12
Cetuximab
11
Trastuzumab
10
Pemetrexed
10
Leucovorin
10
Docetaxel
10
Dexamethasone
10
Oxaliplatin
9
Biopsy
9
pertuzumab
8
olaparib
8
Temozolomide
8
Panitumumab
8
Observation
8
Irinotecan
8
abemaciclib
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Recruiting
×
Neoplasms
×
Low-Level Light Therapy
×
Clear all
NCT06995443
2026-01-30
REGAIN
Centre Hospitalier de Valenciennes
Phase NA
Recruiting
200 enrolled
NCT04979078
2023-06-18
DermLight
Jessa Hospital
Phase NA
Recruiting
40 enrolled